Member Info for CHELSEA7

Nothing to do with taking it personal, just a bit put out by your post. From information that has been emparted i wouldn"t concern yourself with certain individuals ability to risk assess much in our sector. It is by their good judgement they have more balanced portfolios than you or me, and certainly far more profitable.

Really don"t understand Inanaco why you have to say anything bad about leas at all. IMM was an excellent BB in the early days. Often went days without a post then but leas, boomorbust contributed superbly to it. The fact is the share hit 20p before its rather rapid rise to sub £2.00, all i can add is lets hope we see something like that here!!!

Going back to the AGM, and i can"t be sure of this, was it not a question from the floor that sparked comments from the B.O.D.??? I seem to remember concluding that it was rather difficult for a listed company to sell off such a prized asset, certainly one that was instrumental in the share price hitting 64p!!

Just done my shopping and bits, reading this suggests i"m not the only one a bit bored, but as far as leas goes and i only know him as a poster, i have enjoyed his posts, humour and intereactions on these pages for many years, i really am staggered you can see him him in such a light.

Oh well, enjoy the footie, Waitrose Deli, Pizzas and Off Licence seemed rather busy, maybe Football is Coming Home!!!

Always good to see leas posting here, used to enjoy his posts on IMM along with boomorbust for many years. Wanted to repost his of Thursday. Pretty spot on, and leas has enjoyed a few multi baggers in the last year...........................

leas
Posts: 4,435
Opinion: No Opinion
Price: 12.40
RE: Posting rulesThu 13:07Throw my tuppence in here. We assume the market is more enlightened than we are. They always get their targets right. After all they know what deals are being done and who is talking to who.
They thrive on fear and the uncertain they create
I would wager a good sum that if you could ask any of the analysts what value SCLP should be given successful trials they just wouldn't know.
If you ask my gardener to put a value on a blockbuster cancer drug that is not toxic then I would guess in his reply would be billions.
The experts don't know, plain and simple. I have been invested in bios that have released transformational news but takes days for it be digested.
The analysts are good for companies that drop a petrol pump on a well or working out a COS but science is a little more complicated than that.
Remember the MC here is not about the value of that science. It is how that science can become commercial. That valuation could change in a heartbeat in a unforseen RNS.
You guys know that otherwise you would not waste your time posting your views.

Keep the faith or walk away..

That this was trading at sub 1p. It is going the way i thought it would, but remember as i have said before, deals, if you have one, can take a good eighteen months before fruition.

Trust that initial price increase and subsequent movements took many pi"s out of big losses

Ha ha, there were certainly many theories debated here. One was the buy one get one free pitch.!!!

ONW correct. Meant to get over the atmosphere at that meeting with the overriding thoughts, but yes you are right.

Buys 61k

Sells 23k

Hi Balerno,

I actually remember sitting with inanaco, 007 at the AGM five years ago in London. I think it was Evans who said a fair bit of info wouldn"t be published as p.i"s wouldn"t understand it anyway!!!! Didn"t really matter then, SCLP was a two year play with Immunobody being sold after initial trial.

Considering budgets were calculated as per the Admission to AIM documents i think we have handled the huge changes, to finance in particular, rather well. Given those changes hopefully Scancell under CH will ""open the doors" more to us. Hard to argue we don"t need it.

https://in.reuters.com/article/us-astrazeneca-cancer/hitting-cancer-early-astrazenecas-bid-to-outmaneuver-rivals-idINKBN1JW0N5?feedType=RSS&feedName=health&utm_source=Twitter&utm_medium=Social&utm_campaign=Feed%3A+reuters%2FINhealth+%28News+%2F+IN+%2F+Health%29

Leas, there is a point there to note. There are considerably more companies in the Bio-sector than they were six years ago. Many of them i follow, and as a rule are far easier to understand with a bit of research.

That is why i have stated numerous times, that it is far better to simplify what Scancell are doing. Better reword that, we cannot simplify what Scancell do, but the BB should not be directed at Oncologists but the average AIM investor. No criticism meant here at all, but it is pointless to keep asking or stating that the market values us incorrectly, when during busy trading periods we just about reach 75 trades, a mere fraction of the daily trades seen in such shares like N4P etc.

Of course some commercial activity will help put a value here, but simply only £1.2m was raised from an open offer for £2m tells us the weakness in pi support.that we are seeing here, along with a serious lack of "genuine" new posters. I just hope with two trials coming up and the "Moditope Platform" getting nearer to trials the company can help appeal in that respect too. Six or seven trades a day is pathetic, and some want us on NASDAQ??!!! We would never be found!!!!

Have a good weekend all.

Latest Trades
Date & Time Volume Price
06/07/2018 12:24 24,000 12.45 Buy

Well we certainly know SCIB1 Combo is funded, and the vaccine is paid for, prior to latest raising and OO. SCIB 2 Combo Trial is being funded by CRUK...................http://www.lse.co.uk/share-regulatory-news.asp?shareprice=SCLP&ArticleCode=qfkpqd8b&ArticleHeadline=Scancell_and_CRUK_to_advance_cancer_immunotherapy.

Interestingly that news was RNSed on the 14th December 2017, some six months ago now. Another item where an update would be welcome.

I am presuming apart from further clinical development, funding for any trials pertaining to Moditope will be subject to CRUK Grand Challenge award and monetary goldmine. Even more reason to get both SCIBS into trial A.S.A.P. As you rightly point out funding is sorted, not exactly IMO reflective in our share price.

This bouncing back a bit. GL All

2 V 1

Panmure on bid

06/07/2018 12:08 10,000 12.25
06/07/2018 11:42 8,740 12.25
06/07/2018 11:08 4,500 12.35
06/07/2018 09:38 20,000 12.48
06/07/2018 09:18 4,000 12.48

Volume 60k..........................Buys 37k

Judging by my 8.05, fairly confident that will be RNSed next week. Bottomed out?? Just about IMHO

Oliver Sexton, from Midven.....................http://midven.co.uk/

Michael Kipping from innovateuk............https://www.gov.uk/government/organisations/innovate-uk

@BIA_UK
Follow Follow @BIA_UK
More
One week to go til our July 11th, webinar, on the topic of funding your biotech breakthrough. Joining us will be John Glencross of @CalculusCapital , Oliver Sexton of @Midven and Michael Kipping from @innovateuk

Have you signed up yet?

https://bia.me/2IDqfGL

A date for our diaries....................................

SCANCELL Retweeted

Calculus Capital
‏

@CalculusCapital
Jul 4
More Calculus Capital Retweeted BIA
The BIA webinar on 11 July will be chaired by @GlencrossJohn CEO of @CalculusCapitalCalculus Capital added,

BI

""In answer to your IND question, there has been a slight delay given the numerous moving parts in compiling the documentation some of which required third party input, however the IND is in the final stages of consistency checking and once complete it will go to publication. The agency is aware that a submission is forthcoming and subject to a favourable review we expect our study initiation to be on track for the end of this year which is the key event we are focussed on.""

Have a great day all, another week passes.

Lovely message leas, I guess my holiday is in my garden, and to think for four years couldn"t get there. Thank you so much.